Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Bio-Path Holdings, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 392.6K | 412.2K | +19.6K (+5.0%) |
| Value | $1.51M | $1.59M | +$86.0K (+5.7%) |
New holders (2)
Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 18,000 | $70.0K | 0.00% |
| Dimensional Fund Advisors LP | 12,960 | $50.0K | 0.00% |
Sold out (2)
Institutions that held Bio-Path Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Virtu Financial LLC | 10,012 | $38.0K |
| Money Concepts Capital Corp | 300 | $1.00K |